Teva Pharmaceutical Industries Ltd.is investigating whether its drug Laquinimod, which is in a Phase III clinical trial for treating multiple sclerosis, also is suitable for treating lupus.
In March 2010, the federal vaccines court ruled in three separate cases that the mercury-containing preservative thimerosal does not cause autism.
New data reinforce the idea that IgMinduced, complement-mediated nodal injury of peripheral motor nerves generates conduction block and accounts for muscle weakness.
FlexCare Clinical Research LLC is a new niche clinical service provider focused on providing study visits in the home or alternative site settings via a network of skilled clinicians.
A new study discovered evidence that Parkinson’s disease may have an infectious or autoimmune origin.
Amsterdam Molecular Therapeutics has begun a Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B.
According to the U.S. Centers for Disease Control and Prevention, more U.S. teens are getting recommended vaccines against certain cancers, meningitis and infectious diseases.
Global sales of vaccines grew in 2009, according to healthcare market research publisher Kalorama Information, and researchers are forecasting sales to rise at a compound annual rate during the next five years.
A new blood test that will help detect cancer as much as five years earlier than current testing methods has been developed by Oncimmune Ltd.
A new meningitis vaccine will help to prevent epidemics in Africa for the first time.
In June, the state of California declared an epidemic of whooping cough (pertussis) with 910 confirmed cases, making it possible that California will have the largest whooping cough outbreak in 50 years.
Bristol-Myers Squibb’s ipilimumab has shown early promise for helping patients with advanced melanoma that has spread to the brain.